Jehan Dupuis

8.1k total citations
115 papers, 4.1k citations indexed

About

Jehan Dupuis is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Jehan Dupuis has authored 115 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pathology and Forensic Medicine, 49 papers in Genetics and 44 papers in Oncology. Recurrent topics in Jehan Dupuis's work include Lymphoma Diagnosis and Treatment (81 papers), Chronic Lymphocytic Leukemia Research (41 papers) and CNS Lymphoma Diagnosis and Treatment (17 papers). Jehan Dupuis is often cited by papers focused on Lymphoma Diagnosis and Treatment (81 papers), Chronic Lymphocytic Leukemia Research (41 papers) and CNS Lymphoma Diagnosis and Treatment (17 papers). Jehan Dupuis collaborates with scholars based in France, United States and Belgium. Jehan Dupuis's co-authors include Corinne Haïoun, Emmanuel Itti, Michel Meignan, Alain Rahmouni, Christiane Copie‐Bergman, Gaetano Paone, Hervé Tilly, Philippe Gaulard, Olivier Casasnovas and Gilles Salles and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jehan Dupuis

113 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jehan Dupuis France	32	3.1k	1.8k	926	879	729	115	4.1k
Luigi Rigacci Italy	28	3.1k 1.0×	1.6k 0.9×	809 0.9×	842 1.0×	974 1.3×	144	4.0k
Pauline Brice France	23	2.3k 0.7×	1.4k 0.8×	546 0.6×	594 0.7×	722 1.0×	75	3.1k
Pierre Feugier France	26	3.2k 1.0×	2.2k 1.2×	1.4k 1.5×	357 0.4×	876 1.2×	79	3.8k
Judith Trotman Australia	27	2.7k 0.9×	1.3k 0.8×	1.3k 1.4×	738 0.8×	592 0.8×	159	3.6k
Beate Pfistner Germany	16	4.3k 1.4×	2.5k 1.4×	1.1k 1.2×	670 0.8×	1.6k 2.2×	43	5.1k
Karim Belhadj France	25	2.3k 0.8×	1.6k 0.9×	779 0.8×	577 0.7×	704 1.0×	101	3.6k
Catherine Sebban France	24	2.3k 0.7×	1.8k 1.0×	862 0.9×	332 0.4×	575 0.8×	68	3.0k
Christophe Fermé France	26	3.7k 1.2×	2.4k 1.4×	1.2k 1.3×	370 0.4×	1.3k 1.8×	98	4.3k
Éric Van Den Neste Belgium	18	5.5k 1.8×	4.2k 2.4×	2.0k 2.1×	683 0.8×	1.6k 2.2×	46	7.2k
B Coiffier France	18	3.7k 1.2×	2.4k 1.4×	1.4k 1.5×	426 0.5×	1.0k 1.4×	43	4.4k

Countries citing papers authored by Jehan Dupuis

Since Specialization

Citations

This map shows the geographic impact of Jehan Dupuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jehan Dupuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jehan Dupuis more than expected).

Fields of papers citing papers by Jehan Dupuis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jehan Dupuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jehan Dupuis. The network helps show where Jehan Dupuis may publish in the future.

Co-authorship network of co-authors of Jehan Dupuis

This figure shows the co-authorship network connecting the top 25 collaborators of Jehan Dupuis. A scholar is included among the top collaborators of Jehan Dupuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jehan Dupuis. Jehan Dupuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Enouf, Vincent, Giovanna Melica, François Lemonnier, et al.. (2024). Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine. International Journal of Infectious Diseases. 146. 107108–107108. 1 indexed citations

Laribi, Kamel, Stéphanie Poulain, Lise Willems, et al.. (2024). Long‐term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO). British Journal of Haematology. 204(6). 2233–2236. 6 indexed citations

Delfau, Marie Hélène, Emmanuel Bachy, Franck Morschhauser, et al.. (2023). Cell‐free DNA sequencing allows the identification of the mutational profile of TFH lymphomas and has a predictive value: a LYSA study. Hematological Oncology. 41(S2). 338–339. 1 indexed citations

Beldi‐Ferchiou, Asma, Vincent Audard, François Lemonnier, et al.. (2022). Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis. SHILAP Revista de lepidopterología. 3(3). 828–837. 3 indexed citations

Belhadj, Karim, Jehan Dupuis, Louise Roulin, et al.. (2021). Venetoclax induces profound and sustained responses in patients with relapsed/refractory light‐chain amyloidosis. British Journal of Haematology. 193(3). 674–677. 13 indexed citations

Tavernier, Emmanuelle, Frédérique Kuhnowski, Jérôme Tamburini, et al.. (2020). Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin. Bone Marrow Transplantation. 55(9). 1834–1836. 3 indexed citations

Cottereau, Anne‐Ségolène, Annibale Versari, Stefano Luminari, et al.. (2018). Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study. Blood. 131(22). 2449–2453. 52 indexed citations

Bras, Fabien Le, Valérie Molinier‐Frenkel, Aziz Guellich, et al.. (2017). Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis. European Journal of Cancer. 76. 183–187. 15 indexed citations

Sarkozy, Clémentine, Thierry Jo Molina, Hervé Ghesquières, et al.. (2016). Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association. Haematologica. 102(1). 150–159. 33 indexed citations

10.

Attias, Philippe, Anissa Moktefi, Marie Matignon, et al.. (2016). Monotypic plasma cell interstitial nephritis as the only clinical manifestation in a patient with previously undiagnosed indolent multiple myeloma. Medicine. 95(31). e4391–e4391. 6 indexed citations

11.

Sibon, David, Franck Morschhauser, Matthieu Resche‐Rigon, et al.. (2015). Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group. Haematologica. 101(4). 474–481. 28 indexed citations

12.

Cornet, Édouard, Cécile Tomowiak, Aline Schmidt, et al.. (2014). Long‐term follow‐up and second malignancies in 487 patients with hairy cell leukaemia. British Journal of Haematology. 166(3). 390–400. 42 indexed citations

13.

Dupuis, Jehan, Franck Morschhauser, Hervé Ghesquières, et al.. (2014). Final Analysis of the RO-CHOP Phase Ib/II Study: Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphoma (PTCL). Blood. 124(21). 504–504. 11 indexed citations

14.

Ribrag, Vincent, Jehan Dupuis, Hervé Tilly, et al.. (2013). A Dose-Escalation Study of SAR3419, an Anti-CD19 Antibody Maytansinoid Conjugate, Administered by Intravenous Infusion Once Weekly in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. Clinical Cancer Research. 20(1). 213–220. 79 indexed citations

15.

Safar, Violaine, Jehan Dupuis, Emmanuel Itti, et al.. (2011). Interim [ ¹⁸ F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab. Journal of Clinical Oncology. 30(2). 184–190. 124 indexed citations

16.

Caillet, Philippe, Éléna Paillaud, & Jehan Dupuis. (2011). [6/7. Malignant hematological diseases in the elderly].. PubMed. 45–6. 4 indexed citations

17.

Coiffier, Bertrand, Vincent Ribrag, Jehan Dupuis, et al.. (2011). Phase I/II study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered weekly to patients (pts) with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL).. Journal of Clinical Oncology. 29(15_suppl). 8017–8017. 20 indexed citations

18.

Itti, Emmanuel, Chieh Lin, Jehan Dupuis, et al.. (2009). Prognostic Value of Interim ¹⁸F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy. Journal of Nuclear Medicine. 50(4). 527–533. 183 indexed citations

19.

Gouill, Steven Le, Nöel Milpied, Agnès Buzyn, et al.. (2008). Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire. Journal of Clinical Oncology. 26(14). 2264–2271. 208 indexed citations

20.

Lin, Chia-Hung, Emmanuel Itti, Corinne Haïoun, et al.. (2007). Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis. Journal of Nuclear Medicine. 48(10). 1626–1632. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact